Dr Reddy’s settles Millennium’s cancer drug patent suit
Biopharmalex 2018-09-18 1:54 pmBy Miklos Bolza | Sydney
Please login to bookmark Close

Generic drug maker Dr Reddy’s Laboratories has reached a settlement with US-based Millennium Pharmaceuticals, agreeing to be restrained from selling a cheap version of cancer drug Velcade in Australia.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au